ASX - By Stock
|
PPK |
Re:
$50 Party
|
|
Clearlyfacts99
|
854 |
331K |
0 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
854
|
331K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Director Appointment
|
|
Clearlyfacts99
|
21 |
11K |
5 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
21
|
11K
|
5
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Director Appointment
|
|
Clearlyfacts99
|
21 |
11K |
0 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
21
|
11K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Director Appointment
|
|
Clearlyfacts99
|
21 |
11K |
2 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
21
|
11K
|
2
|
|
ASX - By Stock
|
CAN Medicine |
Re:
Interesting cannabis articles and worldwide updates.
|
|
Clearlyfacts99
|
102 |
212K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
102
|
212K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Clearlyfacts99
|
21 |
6.2K |
4 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
21
|
6.2K
|
4
|
|
ASX - By Stock
|
CAN Medicine |
Re:
Interesting cannabis articles and worldwide updates.
|
|
Clearlyfacts99
|
102 |
212K |
0 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
102
|
212K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
60
|
30K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Clearlyfacts99
|
2.3K |
524K |
4 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
2.3K
|
524K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Mid Quarter Update
|
|
Clearlyfacts99
|
15 |
9.5K |
0 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
15
|
9.5K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Mid Quarter Update
|
|
Clearlyfacts99
|
15 |
9.5K |
3 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
15
|
9.5K
|
3
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Mid Quarter Update
|
|
Clearlyfacts99
|
15 |
9.5K |
4 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
15
|
9.5K
|
4
|
|
ASX - By Stock
|
CAN Medicine |
Re:
Interesting cannabis articles and worldwide updates.
|
|
Clearlyfacts99
|
102 |
212K |
1 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
102
|
212K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
2 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
60
|
30K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
2 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
60
|
30K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
3 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
60
|
30K
|
3
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
60
|
30K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Commences Partnership with The Valens Company
|
|
Clearlyfacts99
|
60 |
30K |
4 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
60
|
30K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
7 |
3.4K |
2 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
7
|
3.4K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
7 |
3.4K |
0 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
7
|
3.4K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
7 |
3.4K |
2 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
7
|
3.4K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Q4 2021 Quarterly Update and Appendix 4C
|
|
Clearlyfacts99
|
21 |
11K |
0 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
21
|
11K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Q4 2021 Quarterly Update and Appendix 4C
|
|
Clearlyfacts99
|
21 |
11K |
2 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
21
|
11K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Q4 year on year revenue DOWN over 70%
|
|
Clearlyfacts99
|
3 |
1.8K |
3 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
EPN |
Let Be For Positive 2022
|
|
Clearlyfacts99
|
2 |
1.5K |
0 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
2
|
1.5K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
51 |
31K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
51
|
31K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
51 |
31K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
51
|
31K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Completion of Capital Raising
|
|
Clearlyfacts99
|
24 |
13K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
24
|
13K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
51 |
31K |
2 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
51
|
31K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
51 |
31K |
1 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
51
|
31K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
51 |
31K |
4 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
51
|
31K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Update on Partnership with The Valens Company
|
|
Clearlyfacts99
|
14 |
7.4K |
1 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
14
|
7.4K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Update on Partnership with The Valens Company
|
|
Clearlyfacts99
|
14 |
7.4K |
4 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
14
|
7.4K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Medicinal cannabis supply agreement with Cannvalate
|
|
Clearlyfacts99
|
9 |
2.7K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
9
|
2.7K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
13 |
5.4K |
2 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
13
|
5.4K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
13 |
5.4K |
0 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
13
|
5.4K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
13 |
5.4K |
0 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
13
|
5.4K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
13 |
5.4K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
13
|
5.4K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
1 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
37
|
16K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
0 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
37
|
16K
|
0
|
|
ASX - By Stock
|
ECS |
Re:
Ann: ECS Enters Agreement With Sun Pharma
|
|
Clearlyfacts99
|
93 |
17K |
5 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
93
|
17K
|
5
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
32 |
10K |
4 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Trading Halt
|
|
Clearlyfacts99
|
32 |
10K |
2 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
32
|
10K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
37
|
16K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
37
|
16K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
0 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
37
|
16K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Epsilon clears pathways towards being EBITDA positive in 2022
|
|
Clearlyfacts99
|
37 |
16K |
1 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
37
|
16K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Q3 2021 Quarterly Update and Appendix 4C
|
|
Clearlyfacts99
|
2 |
1.8K |
1 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
2
|
1.8K
|
1
|
|